Novo Nordisk A/S ADR buy Kepler Capital Markets
Start price
13.03.25
/
50%
€71.00
Target price
13.03.26
-
Performance (%)
-16.90%
Price
12:37
€57.90
Summary
This prediction is currently active. The prediction for Novo Nordisk A/S ADR disappoints with a performance of -16.90%. A total of €1.10 was paid as dividends for this prediction. This prediction currently runs until 13.03.26. The prediction end date can be changed by Kepler_Capital_Marke at any time. Kepler_Capital_Marke has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S ADR | -2.357% | -2.357% |
| iShares Core DAX® | -0.727% | 2.783% |
| iShares Nasdaq 100 | 1.839% | 5.294% |
| iShares Nikkei 225® | -2.033% | -0.196% |
| iShares S&P 500 | 1.334% | 4.044% |
Comments by Kepler_Capital_Marke for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) was upgraded by analysts at Kepler Capital Markets from a "hold" rating to a "buy" rating.
Ratings data for NVO provided by MarketBeat